AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RISPERIDONE
207 registrations across 14 African markets— 153 active
Markets with RISPERIDONE
🇿🇦South Africa
103 registrations
79 active
🇲🇦Morocco
25 registrations
25 active
🇹🇳Tunisia
24 registrations
0 active
🇳🇬Nigeria
18 registrations
17 active
🇨🇮Côte d'Ivoire
8 registrations
3 active
🇺🇬Uganda
6 registrations
6 active
🇿🇼Zimbabwe
5 registrations
5 active
🇬🇭Ghana
4 registrations
4 active
🇿🇲Zambia
3 registrations
3 active
🇹🇿Tanzania
3 registrations
3 active
🇸🇳Senegal
3 registrations
3 active
🇲🇬Madagascar
2 registrations
2 active
🇰🇪Kenya
2 registrations
2 active
🇷🇼Rwanda
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CP-RISPERIDONE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | May 2031 |
| NONE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | UTANO GROUP FZC | active | Apr 2031 |
| NONE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | UTANO GROUP FZC | active | Apr 2031 |
| Risperdal 2mg film coated tablets Film-Coated Tablet | 🇰🇪Kenya | Janssen-Cilag NV | active | Mar 2031 |
| Aquatix Risperidone Tablet $ Tablet | 🇳🇬Nigeria | Aquatix Pharmaceuticals Limited | active | Feb 2031 |
| Risdone 2mg Tablet Uncoated | 🇿🇲Zambia | Intas Pharmaceuticals Limited | active | Jul 2030 |
| RISDONE-2 TABLETS | 🇷🇼Rwanda | INTAS PHARMACEUTICALS LIMITED | active | Oct 2029 |
| ASPEN RISPERIDONE ORAL SOLUTION | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Oct 2029 |
| Risdone 1mg tablet Film Coated Tablets | 🇿🇲Zambia | Dar Al Dawa Pharmaceuticals | active | Sept 2029 |
| Risdone 2mg film coated tablet Film Coated Tablets | 🇿🇲Zambia | Dar Al Dawa Pharmaceuticals | active | Sept 2029 |
| Bafnacure 2 mg Tablet** Tablet | 🇳🇬Nigeria | AnnyGod Pharmaceutical Company Ltd | active | Jul 2029 |
| Andro 1 mg Orally Disintegrating Tablet Tablet | 🇳🇬Nigeria | Sai Sagar Pharma Limited | active | Jan 2029 |
| Masrone Tablets** Tablet | 🇳🇬Nigeria | Micro Nova Pharmaceuticals Ind Ltd | active | Jan 2029 |
| RISTABBS 0,5 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Oct 2028 |
| RISTABBS 2 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Oct 2028 |
| Altadon-2 Tablet Tablet | 🇳🇬Nigeria | Pharmacy Plus Ltd | active | Jul 2028 |
| Altadon-1 Tablet Tablet | 🇳🇬Nigeria | Pharmacy Plus Ltd | active | Jul 2028 |
| Risperdal 3 mg Tablet Tablet | 🇳🇬Nigeria | J & J Company West Africa Limited | active | Jul 2028 |
| Amidrex 1 Tablet_ Tablet | 🇳🇬Nigeria | GoldMoore International Limited | active | Jul 2028 |
| Risperdal 2 mg Tablet Tablet | 🇳🇬Nigeria | J & J Company West Africa Limited | active | Jul 2028 |
| Amidrex 2 Tablet_ Tablet | 🇳🇬Nigeria | GoldMoore International Limited | active | Jul 2028 |
| RISPERIDONE BIOGARAN 1MG COMPRIME PELLICULE SECABLE BOITE DE 60 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | May 2028 |
| RISPERIDONE BIOGARAN 4MG COMPRIME PELLICULE SECABLE BOITE DE 30 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | May 2028 |
| RISPERIDONE BIOGARAN 2MG COMPRIME PELLICULE SECABLE BOITE DE 60 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | May 2028 |
| RISPONSE 2 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Dec 2027 |
| RISPONSE 1 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Dec 2027 |
| Zepid 2mg Tablets Film-Coated Tablet | 🇰🇪Kenya | SAI PHARMACEUTICALS LIMITED | active | Sept 2027 |
| RISPERIDONE TABLETS (Each tablet contains Risperidone 2mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| RISPERIDONE TABLETS (Each tablet contains Risperidone 2mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| RISDONE 2mg TABLETS (Each tablet contains Risperidone 2mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| RISDONE 2mg TABLETS (Each tablet contains Risperidone 2mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| Zepidone-0.5 Tablets# Tablet | 🇳🇬Nigeria | Bio-Generics Nigeria Limited | active | Mar 2026 |
| Zepidone 3 Tablets# Tablet | 🇳🇬Nigeria | Bio-Generics Nigeria Limited | active | Mar 2026 |
| Zepidone 2 Tablets# Tablet | 🇳🇬Nigeria | Bio-Generics Nigeria Limited | active | Mar 2026 |
| Afrab Risperidone 4 Caplets_ Caplet | 🇳🇬Nigeria | Afrab-Chem Limited | active | Feb 2026 |
| Afrab Risperidone 2 Caplets_ Caplet | 🇳🇬Nigeria | Afrab-Chem Limited | active | Feb 2026 |
| Car Eva Tablets Tablet | 🇳🇬Nigeria | Jonco Pharmaceutical Company Ltd | active | Dec 2025 |
| Risperidone Sandoz 2 mg Tablet Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Nov 2025 |
| SANDOZ RISPERIDONE 0,5 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| RISNIA 6 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| RISNIA 4 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ADCO-RISPERIDONE 1 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jul 2025 |
| PROPAN-RISPERIDONE 1 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| PROPAN-RISPERIDONE 2 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| PROPAN-RISPERIDONE 0,5 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| PROPAN-RISPERIDONE 4 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| ADCO-RISPERIDONE 3 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| PROPAN-RISPERIDONE 6 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| ADCO-RISPERIDONE 2 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| ADCO-RISPERIDONE 6 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
Showing 50 of 207 registrations. Sign up free to search and export all.
RISPERIDONE in Africa — Regulatory Overview
RISPERIDONE is registered across 14 African markets with 207 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Tunisia, Nigeria and 10 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 207 registrations, 153 (74%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.